These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27069183)

  • 1. Early Response of Esophageal Cancer to Neoadjuvant Chemotherapy with Docetaxel-Cisplatin-5-Fluorouracil Represents Sensitivity: A Phase II Study.
    Matsumoto A; Nishikawa K; Yuda M; Tanaka Y; Tanishima Y; Arakawa Y; Ishibashi Y; Sakuyama T; Omura N; Mitsumori N; Aiba K; Yanaga K
    Anticancer Res; 2016 Apr; 36(4):1937-42. PubMed ID: 27069183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of biweekly docetaxel, cisplatin, and 5-fluorouracil chemotherapy for advanced esophageal squamous cell carcinoma.
    Tanaka Y; Yoshida K; Yamada A; Tanahashi T; Okumura N; Matsuhashi N; Yamaguchi K; Miyazaki T
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1143-52. PubMed ID: 26896963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
    Shim HJ; Cho SH; Hwang JE; Bae WK; Song SY; Cho SB; Lee WS; Joo YE; Na KJ; Chung IJ
    Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of efficacy and safety of first-line docetaxel/cisplatin/5-FU combined therapy for advanced esophageal cancer].
    Minowa M; Kinoshita Y; Hasebe S; Ito T; Ogawa M; Takebayashi K; Ehara K; Ueno M; Udagawa H; Hayashi M
    Gan To Kagaku Ryoho; 2011 Mar; 38(3):393-7. PubMed ID: 21403440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer.
    Watanabe M; Nagai Y; Kinoshita K; Saito S; Kurashige J; Karashima R; Hirashima K; Sato N; Imamura Y; Hiyoshi Y; Baba Y; Iwagami S; Miyamoto Y; Iwatsuki M; Hayashi N; Baba H
    Digestion; 2011; 83(3):146-52. PubMed ID: 21266808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complete response in a case of advanced esophageal cancer treated with docetaxel/5-FU/CDDPand S-1/docetaxel as neoadjuvant chemotherapy].
    Seike J; Matsuoka H; Yuasa Y; Yamai H; Yoshida T; Honda J; Miyoshi T; Tangoku A
    Gan To Kagaku Ryoho; 2008 Apr; 35(4):633-6. PubMed ID: 18408433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
    Yokota T; Hatooka S; Ura T; Abe T; Takahari D; Shitara K; Nomura M; Kondo C; Mizota A; Yatabe Y; Shinoda M; Muro K
    Anticancer Res; 2011 Oct; 31(10):3535-41. PubMed ID: 21965775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of combined chemotherapy with docetaxel, CDDP and 5-FU for highly advanced esophageal cancer.
    Osaka Y; Shinohara M; Hoshino S; Ogata T; Takagi Y; Tsuchida A; Aoki T
    Anticancer Res; 2011 Feb; 31(2):633-8. PubMed ID: 21378349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and S-1 for Resectable Advanced Esophageal Cancer.
    Hayata K; Ojima T; Nakamori M; Nakamura M; Katsuda M; Kitadani J; Takeuchi A; Tabata H; Maruoka S; Yamaue H
    Anticancer Res; 2018 Sep; 38(9):5267-5273. PubMed ID: 30194177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of pathologic complete response of primary esophageal carcinoma treated with 5-FU/CDDP as neoadjuvant chemotherapy].
    Suzuki S; Kaji S; Koike N; Harada N; Tanaka S; Hayashi T; Suzuki M; Hanyu F
    Gan To Kagaku Ryoho; 2009 May; 36(5):839-41. PubMed ID: 19461190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: a phase 2 study.
    Pasini F; de Manzoni G; Zanoni A; Grandinetti A; Capirci C; Pavarana M; Tomezzoli A; Rubello D; Cordiano C
    Cancer; 2013 Mar; 119(5):939-45. PubMed ID: 23165781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A curative resected case of pathological complete response of esophageal carcinoma treated with 5-FU/CDDP as neoadjuvant chemotherapy].
    Kusano T; Noguchi T; Ogawa T; Inomata M; Shiraishi N; Kitano S
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):97-100. PubMed ID: 21368466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of a patient with stage IVa esophageal cancer surviving over 4 years by combination chemotherapy with docetaxel,5 -FU and cisplatin, without operation].
    Yamamoto Y; Ikeda M; Takashima M; Minato T; Furukita Y; Takechi H; Seike J; Tangoku A
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1321-4. PubMed ID: 21829072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of neoadjuvant cisplatin, 5-fluorouracil and interferon-alpha in operable squamous cell carcinoma of the esophagus.
    Bazarbashi S; Abdelsalam M; Amin T; El-Bassiouni M; Soudy H; Elweshi A; Alhusseiny H; Rehman K; Memon M; Ajarim D
    Chemotherapy; 2008; 54(4):315-22. PubMed ID: 18701820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxotere, cisplatin, fluorouracil, and leucovorin (TPFL)as induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Kamnerdsupaphon P; Chitapanarux I; Lorvidhaya V; Sumitsawan Y; Tharavichitkul E; Sukthomya V
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1869-73. PubMed ID: 19011334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer.
    Emi M; Hihara J; Hamai Y; Aoki Y; Okada M; Kenjo M; Murakami Y
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1499-505. PubMed ID: 22382882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 - IIB) cervical cancer: preliminary results of a single-institution experience.
    Huang X; Lan C; Huang H; Zhang Y; Huang H; Cao X; Huang Y; Guo Y; Wan T; Liu J
    Expert Opin Pharmacother; 2011 Feb; 12(2):165-73. PubMed ID: 21226631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of esophageal cancer with multiple lymph node metastases which responded to neoadjuvant chemotherapy (DCF therapy).
    Shimakawa T; Naritaka Y; Asaka S; Isohata N; Yamaguchi K; Murayama M; Konno S; Katsube T; Ogawa K; Ide H
    Anticancer Res; 2010 Jan; 30(1):221-6. PubMed ID: 20150639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.